Menu

Italian Earthquake Researchers Jailed

Seven people, including four scientists, are sentenced to 6 years imprisonment for failing to adequately assess the earthquake risk prior to a deadly 2009 quake.

Oct 23, 2012
Bob Grant

A goverment office In L'Aquila damaged by the 2009 earthquake - Wikimedia, TheWiz83After more than a year in court, an Italian judge has ruled that seven people are guilty of manslaughter for issuing falsely reassuring statements to residents of L'Aquila just days before an earthquake killed more than 300 people in the central Italian town. The seven—which include a volcanologist, a geophysicist, a seismologist, and a professor of seismic engineering, as well as 2 engineers and a government official—were sentenced to 6 years in prison.

On March 31, 2009, just 6 days before the deadly quake struck, the seven convicted people had all participated in a meeting of Italy's National Commission for the Forecast and Prevention of Major Risks, which was held in L'Aquila, as tremors rumbled beneath the town. According to prosecutors in the case, statements made during that meeting indicated that L'Aquila was in no danger of a major quake and misled residents of the town.

"It's incredible that scientists trying to do their job under the direction of a government agency have been convicted for criminal manslaughter," University of Southern California earth scientist Thomas Jordan told ScienceInsider. "We know that the system for communicating risk before the L'Aquila earthquake was flawed, but this verdict will cast a pall over any attempt to improve it. I'm afraid that many scientists are learning to keep their mouths shut."

Lawyers of the seven will appeal the sentence, a process that could take up to 6 years.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!